Estimating Subgroup Effects in Generalizability and Transportability Analyses
- PMID: 35225329
- PMCID: PMC11484600
- DOI: 10.1093/aje/kwac036
Estimating Subgroup Effects in Generalizability and Transportability Analyses
Abstract
Methods for extending-generalizing or transporting-inferences from a randomized trial to a target population involve conditioning on a large set of covariates that is sufficient for rendering the randomized and nonrandomized groups exchangeable. Yet, decision makers are often interested in examining treatment effects in subgroups of the target population defined in terms of only a few discrete covariates. Here, we propose methods for estimating subgroup-specific potential outcome means and average treatment effects in generalizability and transportability analyses, using outcome model--based (g-formula), weighting, and augmented weighting estimators. We consider estimating subgroup-specific average treatment effects in the target population and its nonrandomized subset, and we provide methods that are appropriate both for nested and non-nested trial designs. As an illustration, we apply the methods to data from the Coronary Artery Surgery Study (North America, 1975-1996) to compare the effect of surgery plus medical therapy versus medical therapy alone for chronic coronary artery disease in subgroups defined by history of myocardial infarction.
Keywords: generalizability; heterogeneity of treatment effects; subgroup analysis; transportability.
© The Author(s) 2022. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Similar articles
-
Regression-based estimation of heterogeneous treatment effects when extending inferences from a randomized trial to a target population.Eur J Epidemiol. 2023 Feb;38(2):123-133. doi: 10.1007/s10654-022-00901-5. Epub 2023 Jan 10. Eur J Epidemiol. 2023. PMID: 36626100 Free PMC article. Clinical Trial.
-
Sensitivity analysis using bias functions for studies extending inferences from a randomized trial to a target population.Stat Med. 2023 Jun 15;42(13):2029-2043. doi: 10.1002/sim.9550. Epub 2023 Feb 27. Stat Med. 2023. PMID: 36847107 Free PMC article. Clinical Trial.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Improving transportability of randomized controlled trial inference using robust prediction methods.Stat Methods Med Res. 2023 Dec;32(12):2365-2385. doi: 10.1177/09622802231210944. Epub 2023 Nov 7. Stat Methods Med Res. 2023. PMID: 37936293 Review.
-
Generalisability in economic evaluation studies in healthcare: a review and case studies.Health Technol Assess. 2004 Dec;8(49):iii-iv, 1-192. doi: 10.3310/hta8490. Health Technol Assess. 2004. PMID: 15544708 Review.
Cited by
-
Quantifying and reducing inequity in average treatment effect estimation.BMC Med Res Methodol. 2023 Dec 15;23(1):297. doi: 10.1186/s12874-023-02104-2. BMC Med Res Methodol. 2023. PMID: 38102563 Free PMC article.
-
Regression-based estimation of heterogeneous treatment effects when extending inferences from a randomized trial to a target population.Eur J Epidemiol. 2023 Feb;38(2):123-133. doi: 10.1007/s10654-022-00901-5. Epub 2023 Jan 10. Eur J Epidemiol. 2023. PMID: 36626100 Free PMC article. Clinical Trial.
-
Assessments of the Value of New Interventions Should Include Health Equity Impact.Pharmacoeconomics. 2022 May;40(5):489-495. doi: 10.1007/s40273-022-01131-z. Epub 2022 Mar 3. Pharmacoeconomics. 2022. PMID: 35237944 Free PMC article.
-
Estimation of DAPT Study Treatment Effects in Contemporary Clinical Practice: Findings From the EXTEND-DAPT Study.Circulation. 2022 Jan 11;145(2):97-106. doi: 10.1161/CIRCULATIONAHA.121.056878. Epub 2021 Nov 8. Circulation. 2022. PMID: 34743530 Free PMC article.
References
-
- Dahabreh IJ, Hernán MA. Extending inferences from a randomized trial to a target population. Eur J Epidemiol. 2019;34(8):719–722. - PubMed
-
- Dahabreh IJ, Robertson SE, Steingrimsson JA, et al. Extending inferences from a randomized trial to a new target population. Stat Med. 2020;39(14):1999–2014. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
